Embracing a weight-of-evidence approach for establishing NOAELs for nanoparticle inhalation toxicity studies

Vapor grown carbon fiber combined with polyaniline and gold nanoparticles in composite bioelectrodes and their application in glucose fuel cells

In this study, novel VGCF-based composite bioelectrodes PANI/VGCF/GOx and AuNPsNGCF/GOx are fabricated and compared to CNT-based bioelectrodes.

Low-dose AgNPs reduce lung mechanical function and innate immune defense in the absence of cellular toxicity

Multiple studies have examined the direct cellular toxicity of silver nanoparticles (AgNPs). However, the lung is a complex biological system with multiple cell types and a lipid-rich surface fluid; therefore, organ level responses may not depend on direct cellular toxicity. We hypothesized that interaction with the lung lining is a critical determinant of organ level responses. Here, we have examined the effects of low dose intratracheal instillation of AgNPs (0.05 μg/g body weight) 20 and 110 nm diameter in size, and functionalized with citrate or polyvinylpyrrolidone. Both size and functionalization were significant factors in particle aggregation and lipid interaction in vitro. One day post-intratracheal instillation lung function was assessed, and bronchoalveolar lavage (BAL) and lung tissue collected. There were no signs of overt inflammation. There was no change in surfactant protein-B content in the BAL but there was loss of surfactant protein-D with polyvinylpyrrolidone (PVP)-stabilized particles. Mechanical impedance data demonstrated a significant increase in pulmonary elastance as compared to control, greatest with 110 nm PVP-stabilized particles. Seven days post-instillation of PVP-stabilized particles increased BAL cell counts, and reduced lung function was observed. These changes resolved by 21 days. Hence, AgNP-mediated alterations in the lung lining and mechanical function resolve by 21 days. Larger particles and PVP stabilization produce the largest disruptions. These studies demonstrate that low dose AgNPs elicit deficits in both mechanical and innate immune defense function, suggesting that organ level toxicity should be considered.

Inhaled Titanium Dioxide Nanoparticles: A Review of Their Pulmonary Responses with Particular Focus on the Agglomeration State

Nanotechnology represents major scientific and economic issues for the future. TiO 2 is used as a reference nanoparticle (NP) for research and workplace exposure assessments due to its important industrial production. However, to date little consistent information exists about its human health effects. Approximately 50% of all TiO 2in vivo studies targeting the respiratory tract have been by inhalation and these exposures are often in the form of agglomerates rather than as individual NPs. Therefore, the size of the NP agglomerates represents the effective size interacting with the biological material and could thereby influence the NP mechanisms of action. Thus, interpretation of nanotoxicological data without considering the agglomeration state could partly explain the heterogeneous results found in the scientific literature for TiO 2 NPs. The objective of this review is to examine the literature concerning the importance of TiO 2 aerosol characterization in the assessment of pulmonary toxicity in rodents. In this way, this review reveals that the pulmonary responses following inhalation of TiO 2 NPs might not depend solely on the primary NP size, but also on the crystal phase, the NP agglomerate size, its structure and the mass concentration. It also shows that TiO 2 NPs may exert their toxicity mechanisms specifically because of the size of their agglomerates in aerosols, thus supporting the concept that aerosols composed essentially of small (< 100 nm) or large (> 100 nm) NP agglomerates do not seem to follow the same pulmonary toxicity mechanisms.

Rat pulmonary responses to inhaled nano-TiO₂: effect of primary particle size and agglomeration state

Background

The exact role of primary nanoparticle (NP) size and their degree of agglomeration in aerosols on the determination of pulmonary effects is still poorly understood. Smaller NP are thought to have greater biological reactivity, but their level of agglomeration in an aerosol may also have an impact on pulmonary response. The aim of this study was to investigate the role of primary NP size and the agglomeration state in aerosols, using well-characterized TiO₂ NP, on their relative pulmonary toxicity, through inflammatory, cytotoxic and oxidative stress effects in Fisher 344 male rats.

Methods

Three different sizes of TiO₂ NP, i.e., 5, 10–30 or 50 nm, were inhaled as small (SA) (< 100 nm) or large agglomerates (LA) (> 100 nm) at 20 mg/m³ for 6 hours.

Results

Compared to the controls, bronchoalveolar lavage fluids (BALF) showed that LA aerosols induced an acute inflammatory response, characterized by a significant increase in the number of neutrophils, while SA aerosols produced significant oxidative stress damages and cytotoxicity. Data also demonstrate that for an agglomeration state smaller than 100 nm, the 5 nm particles caused a significant increase in cytotoxic effects compared to controls (assessed by an increase in LDH activity), while oxidative damage measured by 8-isoprostane concentration was less when compared to 10–30 and 50 nm particles. In both SA and LA aerosols, the 10–30 nm TiO₂ NP size induced the most pronounced pro-inflammatory effects compared to controls.

Conclusions

Overall, this study showed that initial NP size and agglomeration state are key determinants of nano-TiO₂ lung inflammatory reaction, cytotoxic and oxidative stress induced effects.